"Olmesartan, but not amlodipine, improved endothelium-dependent coronary dilation despite comparable BP reduction"
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1606, 2007-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Olmesartan medoxomil achieves tighter BP control than amlodipine
Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. :